Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Clinical trial NCT01168713 · COMPLETED
Trial details
- NCT number
- NCT01168713
- Sponsor
- Melinta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2011-07-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.